{"organizations": [], "uuid": "5a7cb8d00de7e19606eb8a61b96492e2b93fd79f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180420.html", "section_title": "Archive News &amp; Video for Friday, 20 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-hemispherx-announces-pricing-of-25/brief-hemispherx-announces-pricing-of-2-57-million-registered-direct-offering-at-a-premium-to-market-idUSASC09WOR", "country": "US", "domain_rank": 408, "title": "BRIEF-Hemispherx Announces Pricing Of $2.57 Million Registered Direct Offering At A Premium To Market", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.056, "site_type": "news", "published": "2018-04-20T22:23:00.000+03:00", "replies_count": 0, "uuid": "5a7cb8d00de7e19606eb8a61b96492e2b93fd79f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-hemispherx-announces-pricing-of-25/brief-hemispherx-announces-pricing-of-2-57-million-registered-direct-offering-at-a-premium-to-market-idUSASC09WOR", "ord_in_thread": 0, "title": "BRIEF-Hemispherx Announces Pricing Of $2.57 Million Registered Direct Offering At A Premium To Market", "locations": [], "entities": {"persons": [{"name": "deepak devalapur", "sentiment": "none"}], "locations": [], "organizations": [{"name": "hemispherx biopharma inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20 (Reuters) - Hemispherx Biopharma Inc:\n* HEMISPHERX ANNOUNCES PRICING OF $2.57 MILLION REGISTERED DIRECT OFFERING AT A PREMIUM TO MARKET\n* HEMISPHERX BIOPHARMA INC - UNDER TERMS OF PURCHASE AGREEMENT, HEMISPHERX HAS AGREED TO SELL ABOUT 6.6 MILLION SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage: (Reporting by Deepak Devalapur)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-20T22:23:00.000+03:00", "crawled": "2018-04-21T18:12:54.046+03:00", "highlightTitle": ""}